Tilray Medical Launches EU-GMP CBD100 Oral Solution in Panama, Expanding Medical Cannabis Access Across Latin America
核心洞察
Tilray Medical (搜索) announced the commercial launch of its Tilray Oral Solution CBD100 (搜索) in Panama, expanding patient access to medical cannabis across Latin America.
The product is manufactured in Portugal under rigorous European Union Good Manufacturing Practice (EU-GMP) standards for use in patients with qualifying medical conditions authorized under Panamanian legislation.
Tilray's Portugal facilities serve as a strategic global export hub, supplying EU-GMP-certified medical cannabis to regulated markets worldwide.
Tilray Medical (搜索) has announced the commercial launch of its Tilray Oral Solution CBD100 (搜索) in Panama, marking a significant step in expanding patient access to medical cannabis across Latin America. The product is intended for use, where authorized, in patients with qualifying medical conditions authorized under Panamanian legislation.
Manufactured in Portugal in accordance with rigorous European Union Good Manufacturing Practice (EU-GMP) standards, the CBD100 (搜索) oral solution reflects Tilray Medical (搜索)'s longstanding commitment to pharmaceutical quality, product consistency, patient safety, and regulatory compliance.
A Strategic Export Hub in Portugal
Tilray Medical (搜索)'s advanced cultivation and manufacturing facilities in Portugal serve as a strategic global export hub, supplying EU-GMP-certified medical cannabis products to regulated markets around the world. The platform enables Tilray Medical to efficiently support growing international demand while maintaining the highest pharmaceutical manufacturing standards across its global operations.
Expanding Access Across Latin America
The Panama launch represents another step in Tilray Medical (搜索)'s broader strategy to expand access across Latin America, an emerging medical cannabis region. As governments across the region continue to establish regulatory pathways for cannabinoid-based medicines, Tilray Medical is well-positioned to support healthcare systems with trusted products, scientific expertise, and a proven track record of operating in highly regulated international markets.
As global acceptance of medical cannabis continues to accelerate, Tilray Medical (搜索) remains focused on advancing patient care, supporting clinical education, investing in research, and expanding access to high-quality medical cannabis products that help address unmet patient needs worldwide.
About Tilray Medical
Tilray Medical (搜索) is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Medical, Good Supply, Redecan, ARX, and Broken Coast. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the largest suppliers of medical cannabis to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.